Non-alcoholic steatohepatitis

1 paper1 finding

Interventions

1

Tirzepatide

downin reviews1

1 study

Tirzepatide decreases non-alcoholic steatohepatitis.
Review
Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs
World journal of methodology21 Aug 2026

More on Tirzepatide

Trial sponsors

Novo Nordisk
Company5 trialsPhase 32,347 people
Boehringer Ingelheim
Company2 trialsPhase 3513 people
NeuroBo Pharmaceuticals
Company1 trialPhase 2109 people
Oramed
Company1 trialPhase 210 people
Redx Pharma
Company1 trialPhase 190 people
German Diabetes Center
1 trialPhase 4192 people
Yonsei University
1 trialPhase 460 people
University of Palermo
1 trialPhase 445 people

Latest

2 in 12 months

Cureus1 Sep

Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes

Systematic review of studies in peopleObesity

World Journal of Methodology21 Aug

Pancreatic-liver crosstalk, novel molecular mediators, and 2025 therapeutic breakthroughs

ReviewMechanisms